szmtag Fructose consumption—free sugars and their health effects (05.02.2021)
DÄ internationalArchive5/2021Fructose consumption—free sugars and their health effects

cme

Fructose consumption—free sugars and their health effects

Dtsch Arztebl Int 2021; 118: 71-80. DOI: 10.3238/arztebl.m2021.0010

Stricker, S; Rudloff, S; Geier, A; Steveling, A; Roeb, E; Zimmer, K

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

Allgemeine Pädiatrie und Neonatologie, Zentrum für Kinderheilkunde und Jugendmedizin, Justus-Liebig-Universität Gießen: Dr. med. Sebastian Stricker, Prof. Dr. oec. throph. Silvia Rudloff, Prof. Dr. med. Klaus-Peter Zimmer
Medizinische Klinik II, Schwerpunkt Hepatologie, Universitätsklinikum Würzburg: Prof. Dr. med. Andreas Geier
Medizinische Klinik A, Abteilung Endokrinologie, Universitätsklinikum Greifswald: Dr. med. Antje Steveling
Schwerpunkt Gastroenterologie, Medizinische Klinik II, Justus-Liebig-Universität Gießen: Prof. Dr. med. Elke Roeb
1.Jagannathan R, Patel SA, Ali MK, Narayan KMV: Global updates on cardiovascular disease mortality trends and attribution of traditional risk factors. Curr Diab Rep 2019; 19: 44 CrossRef MEDLINE
2.Alberti G, Zimmet P, Shaw J, Grundy SM: The IDF consensus worldwide definition of the metabolic syndrome. 2016; www.idf.org/e-library/consensus-statements/60-idfconsensus-worldwide-definitionof-the-metabolic-syndrome (last accessed on 22 July 2019).
3.Abarca-Gómez L, Abdeen ZA, Hamid ZA, et al.: Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet 2017; 390: 2627–42 CrossRef
4.Bentley RA, Ruck DJ, Fouts HN: U.S. obesity as delayed effect of excess sugar. Econ Hum Biol 2020; 36: 100818 CrossRef MEDLINE
5.Ng M, Fleming T, Robinson M, et al.: Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 766–81 CrossRef
6.Schienkiewitz A, Mensink GB, Kuhnert R, Lange C: Übergewicht und Adipositas bei Erwachsenen in Deutschland. JoHM 2017; 2: 21–8.
7.Schienkiewitz A, Brettschneider A, Damerow S, Schaffrath Rosario A: Übergewicht und Adipositas im Kindes- und Jugendalter in Deutschland – Querschnittergebnisse aus KiGGS Welle 2 und Trends. JoHM 2018; 1: 16–23 CrossRef
8.World Health Organization: Guideline: sugars intake for adults and children 2015: www.gbv.eblib.com/patron/FullRecord.aspx?p=2033879 (last accessed on 21 July 2019).
9.Ernst J, Arens-Azevedo U, Bitzer B, et al.: Konsensuspapier: Quantitative Empfehlung zur Zuckerzufuhr in Deutschland. 2018; www.dge.de/fileadmin/public/ doc/ws/stellungnahme/Konsensuspapier_Zucker_DAG_DDG_DGE_2018.pdf (last accessed on 14 July 2019).
10.Birch LL: Development of food preferences. Annu Rev Nutr 1999; 19: 41–62 CrossRef MEDLINE
11.Mennella JA, Finkbeiner S, Lipchock SV, Hwang L-D, Reed DR: Preferences for salty and sweet tastes are elevated and related to each other during childhood. PLoS One 2014; 9: e92201 CrossRef MEDLINE PubMed Central
12.Segovia C, Hutchinson I, Laing DG, Jinks AL: A quantitative study of fungiform papillae and taste pore density in adults and children. Dev Brain Res 2002; 138: 135–46 CrossRef
13.Fidler Mis N, Braegger C, Bronsky J, et al.: Sugar in infants, children and adolescents: a position paper of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr 2017; 65: 681–96 CrossRef MEDLINE
14.Perrar I, Schadow AM, Schmitting S, Buyken AE, Alexy U: Time and age trends in free sugar intake from food groups among children and adolescents between 1985 and 2016. Nutrients 2019; 12: 20 CrossRef MEDLINE PubMed Central
15.Rabenberg M, Mensink GBM für Robert Koch-Institut Berlin: Limo, Saft & Co – Konsum zuckerhaltiger Getränke in Deutschland. GBE kompakt 2013; 4.
16.Johnson RJ, Segal MS, Sautin Y, et al.: Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease and cardiovascular disease. Am J Clin Nutr 2007; 86: 899–906.
17.Sievenpiper JL, de Souza RJ, Mirrahimi A, et al.: Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis. Ann Intern Med 2012; 156: 291–304 CrossRef MEDLINE
18.Disse SC, Buelow A, Boedeker R-H, et al.: Reduced prevalence of obesity in children with primary fructose malabsorption: a multicentre, retrospective cohort study. Pediatr Obes 2013; 8: 255–8 CrossRefMEDLINE
19.Te Morenga L, Mallard S, Mann J: Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies. BMJ 2012; 346: e7492 CrossRef MEDLINE
20.Wang DD, Sievenpiper JL, Souza RJ de, et al.: Effect of fructose on postprandial triglycerides: a systematic review and meta-analysis of controlled feeding trials. Atherosclerosis 2014; 232: 125–33 CrossRef MEDLINE
21.Chiavaroli L, Souza RJ de, Ha V, et al.: Effect of fructose on established lipid targets: a systematic review and meta-analysis of controlled feeding trials. J Am Heart Assoc 2015; 4: e001700 CrossRef MEDLINE PubMed Central
22.Schwingshackl L, Neuenschwander M, Hoffmann G, Buyken AE, Schlesinger S: Dietary sugars and cardiometabolic risk factors: a network meta-analysis on isocaloric substitution interventions. Am J Clin Nutr 2020; 111: 187–96 CrossRef MEDLINE
23.Becker B de, Borghi C, Burnier M, van de Borne P: Uric acid and hypertension: a focused review and practical recommendations. J Hypertens 2019; 37: 878–83 CrossRef MEDLINE
24.Feig DI, Kang D-H, Johnson RJ: Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811–21 CrossRef MEDLINE PubMed Central
25.Perez-Pozo SE, Schold J, Nakagawa T, Sánchez-Lozada LG, Johnson RJ, Lillo JL: Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes (Lond) 2010; 34: 454–61 CrossRef MEDLINE
26.Wang DD, Sievenpiper JL, Souza RJ de, et al.: The effects of fructose intake on serum uric acid vary among controlled dietary trials. J Nutr 2012; 142: 916–23 CrossRef MEDLINE PubMed Central
27.Jayalath VH, Sievenpiper JL, Souza RJ de, et al.: Total fructose intake and risk of hypertension: a systematic review and meta-analysis of prospective cohorts. J Am Coll Nutr 2014; 33: 328–39 CrossRef MEDLINE PubMed Central
28.Kelishadi R, Mansourian M, Heidari-Beni M: Association of fructose consumption and components of metabolic syndrome in human studies: a systematic review and meta-analysis. Nutrition 2014; 30: 503–10 CrossRef MEDLINE
29.Gois PHF, Souza ERdM: Pharmacotherapy for hyperuricemia in hypertensive patients. Cochrane Database Syst Rev 2017; 4: CD008652 CrossRef MEDLINE PubMed Central
30.Evans RA, Frese M, Romero J, Cunningham JH, MIlls KE: Fructose replacement of glucose or sucrose in food or beverages lowers postprandial glucose and insulin without raising triglycerides: a systematic review and meta-analysis. Am J Clin Nutr 2017; 106: 506–18 CrossRef MEDLINE
31.Malik VS, Popkin BM, Bray GA, Després J-P, Willett WC, Hu FB: Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 2010; 33: 2477–83 CrossRef MEDLINE PubMed Central
32.Romaguera D, Norat T, Wark PA, et al.: Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct. Diabetologia 2013; 56: 1520–30 CrossRef MEDLINE
33.Ter Horst KW, Schene MR, Holman R, Romijn JA, Serlie MJ: Effect of fructose consumption on insulin sensitivity in nondiabetic subjects: a systematic review and meta-analysis of diet-intervention trials. Am J Clin Nutr 2016; 104: 1562–76 CrossRef MEDLINE
34.Weiß J, Rau M, Geier A: Non-alcoholic fatty liver disease—epidemiology, clincal course, investigation and treatment. Dtsch Arztebl Int 2014; 111: 447−52 CrossRef MEDLINE PubMed Central
35.Roeb E, Steffen HM, Bantel H, et al.: S2k Leitlinie Nicht-alkoholische Fettlebererkrankungen. AWMF Register Nr. 021–025. 2015; www.awmf.org/uploads/tx_szleitlinien/021-025l_S25_NASH_Nicht_alkoholische Fettlebererkrankung_2015–01.pdf (last accessed on 16 February 2020).
36.Loomba R, Sanyal AJ: The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 2013; 10: 686–90 CrossRef MEDLINE
37.Abid A, Taha O, Nseir W, Farah R, Grosovski M, Assy N: Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J Hepatol 2009; 51: 918–24 CrossRef MEDLINE
38.Chiu S, Sievenpiper JL, Souza RJ de, et al.: Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr 2014; 68: 416–23 CrossRef MEDLINE PubMed Central
39.Chung M, Ma J, Patel K, Berger S, Lau J, Lichtenstein AH: Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis. Am J Clin Nutr 2014; 100: 833–49 CrossRef MEDLINE PubMed Central
e1.Thelen J, Kirsch N, Hoebel J: Health in Europe – Data from the EU Health Monitoring Programme. Robert Koch-Institut Berlin. GBE kompakt 2012; 3.
e2.Steigender Zuckerkonsum. Sachstand WD 9 – 3000 – 053/16. Zahlen, Positionen und Steuerungsmaßnahmen. 2016; www.bundestag.de/resource/blob/480534/0ae314792d88005c74a72378e3a42aec/wd-9-053-16-pdf-data.pdf (last accessed on 14 July 2019).
e3.Kurth B-M, Schaffrath Rosario A: Die Verbreitung von Übergewicht und Adipositas bei Kindern und Jugendlichen in Deutschland. Ergebnisse des bundesweiten Kinder- und Jugendgesundheitssurveys (KiGGS) [The prevalence of overweight and obese children and adolescents living in Germany. Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007; 50: 736–43 CrossRef MEDLINE
e4.Stevens B, Yamada J, Ohlsson A, Haliburton S, Shorkey A: Sucrose for analgesia in newborn infants undergoing painful procedures. Cochrane Database Syst Rev 2016; 7: CD001069 CrossRef MEDLINE PubMed Central
e5.Gibbins S, Stevens B: Mechanisms of sucrose and non-nutritive sucking in procedural pain management in infants. Pain Res Manag Spring 2001; 6: 21–8 CrossRef MEDLINE
e6.Mennella JA, Coren PJ, Jagnow MS, Beauchamp GK: Prenatal and postnatal flavor learning by human infants. Pediatrics 2012; 107: E88 CrossRef MEDLINE PubMed Central
e7.Nehring I, Kostka T, Kries R von, Rehfuess EA: Impacts of in utero and early infant taste experiences on later taste acceptance: a systematic review. J Nutr 2015; 145: 1271–9 CrossRef MEDLINE
e8.Bagus T, Roser S, Watzl B für Max Rubner-Institut, Bundesforschungsinstitut für Ernährung und Lebensmittel: Reformulierung von verarbeiteten Lebensmitteln – Bewertungen und Empfehlungen zur Reduktion des Zuckergehalts 2016: www.mri.bund.de/fileadmin/MRI/Themen/Reformulierung/Reformulierung_Thema-Zucker.pdf (last accessed on 22 July 2019).
e9.Richter A, Heidemann C, Schulze MB, Roosen J, Thiele S, Mensink GB: Dietary patterns of adolescents in Germany—associations with nutrient intake and other health related lifestyle characteristics. BMC Pediatr 2012; 12: 35 CrossRef MEDLINE PubMed Central
e10.Hanover LM, White JS: Manufacturing, composition, and applications of fructose. Am J Clin Nutr 1993; 58 (Suppl): 724–32 CrossRef MEDLINE
e11.Bantle JP, Slama G: Is fructose the optimal low glycemic index sweetener? Nutritional management of diabetes mellitus and dysmetabolic syndrome. Nestlé Nutr Workshop Ser Clin Perform Program 2006; 11: 83–95 CrossRef MEDLINE
e12.Gaby AR: Adverse effects of dietary fructose. Altern Med Rev 2005; 10: 294–306.
e13.Bray GA, Nielsen SJ, Popkin BM: Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004; 79: 537–43 CrossRef MEDLINE
e14.Jürgens H, Haass W, Castaneda TR, et al.: Consuming fructose-sweetened beverages increases body adiposity in mice. Obes Res 2005; 13: 1146–56 CrossRef MEDLINE
e15.Bocarsly ME, Powell ES, Avena NM, Hoebel BG: High-fructose corn syrup causes characteristics of obesity in rats: increased body weight, body fat and triglyceride levels. Pharmacol Biochem Behav 2010; 97: 101–6 CrossRef MEDLINE PubMed Central
e16.Nagai Y, Yonemitsu S, Erion DM, et al.: The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. Cell Metab 2009; 9: 252–64 CrossRef MEDLINE PubMed Central
e17.Chong MF, Fielding BA, Frayn KN: Mechanisms for the acute effect of fructose on postprandial lipemia. Am J Clin Nutr 2007; 85: 1511–20 CrossRef MEDLINE
e18.Parks EJ, Skokan LE, Timlin MT, Dingfelder CS: Dietary sugars stimulate fatty acid synthesis in adults. J Nutr 2008; 138: 1039–46 CrossRef MEDLINE PubMed Central
e19.Macedo RCO, Vieira AF, Moritz CEJ, Reischak-Oliveira A: Effects of fructose consumption on postprandial TAG: an update on systematic reviews with meta-analysis. Br J Nutr 2018; 120: 364–72 CrossRef MEDLINE
e20.Crescenzo R, Bianco F, Coppola P, et al.: Adipose tissue remodeling in rats exhibiting fructose-induced obesity. Eur J Nutr 2014; 53: 413–9 CrossRef MEDLINE
e21.Maersk M, Belza A, Stødkilde-Jørgensen H, et al.: Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr 2012; 95: 283–9 CrossRef MEDLINE
e22.Stanhope KL, Schwarz JM, Keim NL, et al.: Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009; 119: 1322–34 CrossRef MEDLINE PubMed Central
e23.Nakagawa T, Hu H, Zharikov S, et al.: A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006; 290: F625–31 CrossRef MEDLINE
e24.Teff KL, Elliott SS, Tschöp M, et al.: Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab 2004; 89: 2963–72 CrossRef MEDLINE
e25.Ter Horst KW, Serlie MJ: Fructose consumption, lipogenesis, and non-alcoholic fatty liver disease. Nutrients 2017; 9: 981 CrossRef MEDLINE PubMed Central
e26.Ouyang X, Cirillo P, Sautin Y, et al.: Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 2008; 48: 993–9 CrossRef MEDLINE PubMed Central
e27.Mosca A, Nobili V, De Vito R, et al.: Uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents. J Hepatol 2017; 66: 1031–6 CrossRef MEDLINE
e28.Abdelmalek MF, Suzuki A, Guy C, et al.: Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 2010; 51: 1961–71 CrossRef MEDLINE PubMed Central
e29.Kanerva N, Sandboge S, Kaartinen NE, Männistö S, Eriksson JG: Higher fructose intake is inversely associated with risk of nonalcoholic fatty liver disease in older Finnish adults. Am J Clin Nutr 2014; 100: 1133–8 CrossRef MEDLINE
e30.Pyrrolizidinalkaloide in Kräutertees und Tees – Stellungnahme 018/2013 des BfR vom 5. Juli 2013. www.bfr.bund.de/cm/343/pyrrolizidinalkaloide-in-kraeutertees-und-tees.pdf (last accessed on 26 September 2020).
e31.Ruyter JC de, Olthof MR, Seidell JC, Katan MB: A trial of sugar-free or sugar-sweetened beverages and body weight in children. N Engl J Med 2012; 367: 1397–406 CrossRef MEDLINE
e32.Ebbeling CB, Feldman HA, Chomitz VR, et al.: A randomized trial of sugar-sweetened beverages and adolescent body weight. N Engl J Med 2012; 367: 1407–16 CrossRef MEDLINE PubMed Central